We are live on !
Find out more
AstraZeneca
AZN
AZN
331 hedge funds and large institutions have $5.85B invested in AstraZeneca in 2013 Q2 according to their latest regulatory filings, with 331 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
222% more call options, than puts
Call options by funds: $107M | Put options by funds: $33.3M
9.87% more ownership
Funds ownership: 0% → 9.87% (+9.9%)
Holders
331
Holders Change
+331
Holders Change %
–
% of All Funds
10.76%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.16%
New
331
Increased
–
Reduced
–
Closed
–
Calls
$107M
Puts
$33.3M
Net Calls
+$74.1M
Net Calls Change
+$74.1M
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
AZN Hedge Fund Activity: Q2 2013 in Review
331 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZN) for Q2 2013, worth a combined $5.85B.
Buyers outnumbered sellers: 331 funds opened new AZN positions and 0 closed out — a net gain of 331 holders — while 0 added to existing stakes and 0 trimmed.
- 331 institutional investors held AstraZeneca (AZN) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $5.85B of AstraZeneca stock for Q2 2013.
- 331 funds opened new AstraZeneca positions in Q2 2013 and 0 closed out, a net change of +331 holders.
Based on aggregated 13F filings for Q2 2013.